Analysts ‘extremely bullish’ as Telix beams into Novartis’ territory with $1.6B ITM acquisition - Fierce Biotech
Source: Fierce Biotech ·
Analysts ‘extremely bullish’ as Telix beams into Novartis’ territory with $1.6B ITM acquisition Fierce BiotechRadiopharma companies merge after one receives surprise FDA rejection STATTelix to buy Germany’s ITM Isotope for $1.65B to expand radiopharma footprint (TLX:NASDAQ) Seeking AlphaWhy This Biotech Crashed On Its Proposed $2.35 Billion Merger Investor's Business DailyTLX: US$1.65B…